Overview

A Study of HG146 Capsule in Chinese Subjects With Relapsed and Refractory Multiple Myeloma

Status:
Recruiting
Trial end date:
2022-06-12
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the tolerability and safety of HG146 capsule in patients with multiple myeloma.
Phase:
Phase 1
Details
Lead Sponsor:
HitGen Inc.
HitGen Ltd